REFERENCES

1. Gnoth C, Godehardt E, Frank-Herrmann P, Friol K, Tigges JG. Definition and prevalence of subfertility and infertility. Hum Reprod 2005;20:1144-47.

2. Te Velde ER, Eijkemans R, Habbema HD.

3. Habbema JDF, Collins J, Leridon H, Evers JLH, Lunenfeld B, teVelde ER. Towards less confusing terminology in reproductive medicine: a proposal. Hum Reprod 2004;19:1497-501.

4. Joffe M. Time trends in biological fertility in Britain. Lancet 2000;355:1961-65.

5. Zegers- Hochschild F, Adamson GD, de Mouzon J, et al. International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. Fertil Steril 2009;92:1520-24.

6. World Health Organization. The Epidemiology of Infertility. Report of WHO Scientific Group on the Epidemiology ofInfertility. Technical Report Series No. 582. Geneva: World Health Organization; 1975.

7. Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, regional, and global trends in infertility: a system­atic analysis of 277 health surveys. PLoS Med 2012;9:e1001356.

8. Gurunath S, Pandian Z, Anderson Richard A, Bhattacharya S. Defining infertility—a systematic review of prevalence studies. Hum Reprod Update 2011;17:575-88.

9. Boivin J, Bunting L, Collins JA, Nygren KG. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod 2007;22:1506-12.

10. National Institute for Health and Clinical Excellence (NICE). Fertility: Assessment and Treatment for People with Fertility Problems. Clinical guideline [CG156], last updated September 2017. London: NICE; 2013.

11. Bhattacharya S, Porter M, Amalraj E, et al.

12. te Velde ER, Scheffer GJ, Dorland M, Broekmans FJ, Fauser BC. Developmental and endocrine aspects of normal ovarian aging. Cell Endocrinol 1998;145:67-73.

13. Sartorius GA, Nieschlag E. Paternal age and reproduction. Hum Reprod Update 2010;16:65-79.

14. Rittenberg V, Seshadri S, Sunkara SK, et al. Effect of body mass index on IVF treatment outcome: an updated systematic review and meta-analysis. Reprod Biomed Online 2011;23:421-39.

15. Sermondade N, Faure C, Fezeu L, et al. BMI in relation to sperm count: an updated systematic review and collaborative meta-ana- lysis. Hum Reprod Update 2013;19:221-31.

16. Augood C, Duckitt K, Templeton AA. Smoking and female in­fertility: a systematic review and meta-analysis. Hum Reprod 1998;13:1532-39.

17. Hull MG, North K, Taylor H, Farrow A, Ford WC. Delayed concep­tion and active and passive smoking. The Avon Longitudinal Study of Pregnancy and Childhood Study Team. Fertil Steril 2000;74:725-33.

18. Waylen AL, Metwally M, Jones GL, Wilkinson AJ, Ledger WL. Effects of cigarette smoking upon clinical outcomes of assisted re­production: a meta-analysis. Hum Reprod Update 2009;15:31-44.

19. Hyland A, Piazza K, Hovey KM, et al. Associations between lifetime tobacco exposure with infertility and age at natural menopause: the Women’s Health Initiative Observational Study. Tob Control 2016;25:706-14.

20. Kunzle R, Mueller MD, Hanggi W, Birkhauser MH, Drescher H, Bersinger NA. Semen quality of male smokers and nonsmokers in infertile couples. Fertil Steril 2003;79:287-91.

21. Tolstrup JS, Kjaer SK, Holst C, et al. Alcohol use as predictor for infertility in a representative population of Danish women. Acta Obstet Gynecol Scand 2003;82:744-49.

22. Eggert J, Theobald H, Engfeldt P. Effects of alcohol consump­tion on female fertility during an 18-year period. Fertil Steril 2004;81:379-83.

23. Brandes M, van der Steen JO, Bokdam SB, et al.

24. Lynch CD, Sundaram R, Maisog JM, Sweeney AM, Buck Louis GM. Preconception stress increases the risk of infertility: results from a couple-based prospective cohort study—the LIFE study. Hum Reprod 2014;29:1067-75.

25. Peck JD, Leviton A, Cowan LD. A review of the epidemiologic evi­dence concerning the reproductive health effects of caffeine con­sumption: a 2000-2009 update. Food Chem Toxicol 2010;48:2549-76.

26. Bosteels J, Kasius J, Weyers S, Broekmans FJ, Mol BW, D’Hooghe TM. Hysteroscopy for treating subfertility associated with sus­pected major uterine cavity abnormalities. Cochrane Database Syst Rev 2015;2:CD009461.

27. Jayaprakasan K, Chan YY, Sur S, Deb S, Clewes JS, Raine-Fenning NJ. Prevalence of uterine anomalies and their impact on early pregnancy in women conceiving after assisted reproduction treat­ment. Ultrasound Obstet Gynecol 2011;37:727-32.

28. Guermandi E, Vegetti W, Bianchi MM, Uglietti A, Ragni G, Crosignani P. Reliability of ovulation tests in infertile women. Obstet Gynecol 2001;97:92-96.

29. Maheux-Lacroix S, Boutin A, Moore L, et al. Hysterosalpingo- sonography for diagnosing tubal occlusion in subfertile women: a systematic review with meta-analysis. Hum Reprod 2014;29:953-63.

30. Cooper TG, Noonan E, von Eckardstein S, et al. World Health Organization reference values for human semen characteristics. Reprod Update 2010;16:231-45.

31. Guzick DS, Overstreet JW, Factor-Litvak P, et al. Sperm morph­ology, motility, and concentration in fertile and infertile men. N Engl JMed 2001;345:1388-93.

32. Silber SJ. The relationship of abnormal semen parameters to male fertility. Hum Reprod 1989;4:947-53.

33. Pereira R, Sa R, Barros A, Sousa M. Major regulatory mechanisms involved in sperm motility. Asian J Androl 2017;19:5-14.

34. Auger J, Jouannet P, Eustache F.

35. Broekmans FJ, Kwee, J, Hendriks DJ, Mol BW, Lambalk CB. A sys­tematic review of tests predicting ovarian reserve and IVF out­come. Hum Reprod Update 2006;12:685-718.

36. Gibreel A, Maheshwari A, Bhattacharya S, Johnson NP. Ultrasound tests of ovarian reserve; a systematic review of accuracy in predicting fertility outcomes. Hum Fertil (Camb) 2009;12:95-106.

37. Broer SL, Dolleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJ. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update 2011;17:46-54.

38. Depmann M, Broer SL, van der Schouw YT, et al. Can we predict age at natural menopause using ovarian reserve tests or mother’s age at menopause? A systematic literature review. Menopause 2016;23:224-32.

39. Bingol B, Gunenc Z, Gedikbasi A, Guner H, Tasdemir S, Tiras B. Comparison of diagnostic accuracy of saline infusion sonohysterography, transvaginal sonography and hysteroscopy. Obstet Gynaecol 2011;31:54-58.

40. Bosteels J, Weyers S, Puttemans P, et al. The effectiveness of hysteroscopy in improving pregnancy rates in subfertile women without other gynaecological symptoms: a systematic review. Hum Reprod Update 2010;16:1-11.

41. Brandes M, Hamilton CJ, van der Steen JO, et al. Unexplained in­fertility: overall ongoing pregnancy rate and mode of conception. Hum Reprod 2011;26:360-68.

42. Verkauf BS. Incidence, symptoms, and signs of endometriosis in fertile and infertile women. J Fla Med Assoc 1987;74:671-75.

43. Endometriosis and infertility: a committee opinion. The Practice Committee of the American Society for Reproductive Medicine. Fertil Steril 2006;86 Suppl 6: S156-60.

44. Moran LJ, Hutchison SK, Norman RJ, Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2011;7:CD007506.

45. Bjornholt SM, Kjaer SK, Nielsen TS, Jensen A. Risk for border­line ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.

46. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 2008;23:462-77.

47. Beck JI, Boothroyd C, Proctor M, Farquhar C, Hughes E. Oral anti-oestrogens and medical adjuncts for subfertility associated with anovulation. Cochrane Database Syst Rev 2005;1:CD002249.

48. Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH. Insulin­sensitising drugs (metformin, rosiglitazone, pioglitazone, D- chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 2012;5:CD003053.

49. Franik S, Kremer JA, Nelen WL, Farquhar C. Aromatase in­hibitors for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev 2014;2:CD010287.

50. Farquhar C, Brown J, Marjoribanks J. Laparoscopic drilling by diathermy or laser for ovulation induction in anovula­tory polycystic ovary syndrome. Cochrane Database Syst Rev 2012;6:CD001122.

51. Toulis KA, Goulis DG, Venetis CA, et al. Risk of spontaneous miscarriage in euthyroid women with thyroid autoimmunity undergoing IVF: a meta-analysis. Eur J Endocrinol 2010;162: 643-52.

52. Spencer L, Bubner T, Bain E, Middleton P. Screening and subse­quent management for thyroid dysfunction pre-pregnancy and during pregnancy for improving maternal and infant health. Cochrane Database Syst Rev 2015;9:CD011263.

53. Gomel V. The place of reconstructive tubal surgery in the era of assisted reproductive techniques. Reprod Biomed Online 2015;31:722-31.

54. Li X, Dong L, Yong S, Wei H. Reproductive outcomes after opera­tive laparoscopy of patients with tubal infertility with or without hydrosalpinx. Chin Med J 2014;127:593-94.

55. Johnson N, van Voorst S, Sowter MC, Strandell A, Mol BW. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database Syst Rev 2010;1:CD002125.

56. Showell MG, Mackenzie-Proctor R, Brown J, Yazdani A, Stankiewicz MT, Hart RJ.

57. Rastrelli G, Corona G, Mannucci E, Maggi M. Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta-analytic study. Andrology 2014;2:794-808.

58. Yafi FA, Zini A. Percutaneous epididymal sperm aspiration for men with obstructive azoospermia: predictors of successful sperm retrieval. Urology 2013;82:341-44.

59. Van Peperstraten A, Proctor ML, Johnson NP, Philipson G. Techniques for surgical retrieval of sperm prior to ICSI for azoo­spermia. Cochrane Database Syst Rev 2006;3:CD002807.

60. Cissen M, Bensdorp A, Cohlen BJ, Repping S, de Bruin JP, van Wely M. Assisted reproductive technologies for male subfertility. Cochrane Database Syst Rev 2016;2:CD000360.

61. Kersten FA, Hermens RP, Braat DD, et al. Overtreatment in couples with unexplained infertility. Hum Reprod 2015;30:71-80.

62. Hunault CC, Habbema JD, Eijkemans MJ, et al. Two new pre­diction rules for spontaneous pregnancy leading to live birth among subfertile couples, based on the synthesis of three previous models. Hum Reprod 2004;19:2019-26.

63. Wordsworth S, Buchanan J, Mollison J, et al. Clomiphene citrate and intrauterine insemination as first-line treatments for unexplained infertility: are they cost-effective? Hum Reprod 2011;26:369-75.

64. Hughes E, Brown J, Collins JJ, et al. Clomiphene citrate for un­explained subfertility in women. Cochrane Database Syst Rev 2010;1:CD000057.

65. Bhattacharya S, Harrild K, Mollison J, et al. Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomised controlled trial. BMJ 2008;337:a716.

66. Veltman-Verhulst SM, Cohlen BJ, Hughes E, et al. Intrauterine in­semination for unexplained subfertility. Cochrane Database Syst Rev 2013;10:CD001502.

67. Bensdorp AJ, Tjon-Kon-Fat RI, Bossuyt PM, et al. Prevention of multiple pregnancies in couples with unexplained or mild male subfertility: randomised controlled trial of in vitro fertilisation with single embryo transfer or in vitro fertilisation in modified natural cycle compared with intrauterine insemination with con­trolled ovarian hyperstimulation. BMJ 2015;350:g7771.

68. Reindollar RH, Regan MM, Neumann PJ, et al. A randomized clinical trial to evaluate optimal treatment for unexplained infer­tility: the fast track and standard treatment (FASTT) trial. Fertil Steril 2010;94:888-99.

69. Pandian Z, Gibreel A, Bhattacharya S. In vitro fertilisa­tion for unexplained subfertility. Cochrane Database Syst Rev 2015;11:CD003357.

70. Hughes E, Brown J, Collins JJ, Farquhar C, Fedorkow DM, Vandekerckhove P. Ovulation suppression for endometriosis. Cochrane Database Syst Rev 2007;3:CD000155.

71. Jacobson TZ, Duffy JM, Barlow D, Farquhar C, Koninckx PR, Olive D. Laparoscopic surgery for subfertility associated with endometriosis. Cochrane Database Syst Rev 2010;1:CD001398.

72. Dunselman GA, Vermeulen N, Becker C, et al. ESHRE guide­line: management of women with endometriosis. Hum Reprod 2014;29:400-12.

73. Hart RJ, Hickey M, Maouris P, Buckett W. Excisional surgery versus ablative surgery for ovarian endometriomata. Cochrane Database Syst Rev 2008;2:CD004992.

74. Garcia-Velasco JA, Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod 2009;24:496-501.

75. Sallam HN, Garcia-Velasco JA, Dias S, Arici A. Long-term pitu­itary down- regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev 2006:CD004635.

76. Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometri­osis on in vitro fertilization. Fertil Steril 2002;77:1148-55.

77. Smith AD, Tilling K, Nelson SM, Lawlor DA. Live-birth rate as­sociated with repeat in vitro fertilization treatment cycles. JAMA 2015;314:2654-62.

78. McLernon DJ, Maheshwari A, Lee AJ, Bhattacharya S. Cumulative live birth rates after one or more complete cycles of IVF: a popula­tion-based study of linked cycle data from 178 898 women. Hum Reprod 2016;31:572-81.